These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 1535533

  • 21. Autoradiographic studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity. I. 6-OHDA lesions of ascending mesencephalic dopaminergic pathways in the rat.
    Graham WC, Crossman AR, Woodruff GN.
    Brain Res; 1990 Apr 23; 514(1):93-102. PubMed ID: 2113410
    [Abstract] [Full Text] [Related]

  • 22. Dopaminergic grafts in the striatum reduce D1 but not D2 receptor-mediated rotation in 6-OHDA-lesioned rats.
    Robertson GS, Fine A, Robertson HA.
    Brain Res; 1991 Jan 25; 539(2):304-11. PubMed ID: 1675908
    [Abstract] [Full Text] [Related]

  • 23. Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine.
    Przedborski S, Levivier M, Jiang H, Ferreira M, Jackson-Lewis V, Donaldson D, Togasaki DM.
    Neuroscience; 1995 Aug 25; 67(3):631-47. PubMed ID: 7675192
    [Abstract] [Full Text] [Related]

  • 24. Treadmill exercise suppresses nigrostriatal dopaminergic neuronal loss in 6-hydroxydopamine-induced Parkinson's rats.
    Yoon MC, Shin MS, Kim TS, Kim BK, Ko IG, Sung YH, Kim SE, Lee HH, Kim YP, Kim CJ.
    Neurosci Lett; 2007 Aug 09; 423(1):12-7. PubMed ID: 17644250
    [Abstract] [Full Text] [Related]

  • 25. Substantia nigra 6-hydroxydopamine lesions alter dopaminergic synaptic markers in the nucleus basalis magnocellularis and striatum of rats.
    Geula C, Slevin JT.
    Synapse; 1989 Aug 09; 4(3):248-53. PubMed ID: 2532792
    [Abstract] [Full Text] [Related]

  • 26. Time course of striatal changes induced by 6-hydroxydopamine lesion of the nigrostriatal pathway, as studied by combined evaluation of rotational behaviour and striatal Fos expression.
    Labandeira-Garcia JL, Rozas G, Lopez-Martin E, Liste I, Guerra MJ.
    Exp Brain Res; 1996 Feb 09; 108(1):69-84. PubMed ID: 8721156
    [Abstract] [Full Text] [Related]

  • 27. Adrenal medulla grafts in the hemiparkinsonian rat: profile of behavioral recovery predicts restoration of the symmetry between the two striata in measures of pre- and postsynaptic dopamine function.
    Curran EJ, Albin RL, Becker JB.
    J Neurosci; 1993 Sep 09; 13(9):3864-77. PubMed ID: 8103552
    [Abstract] [Full Text] [Related]

  • 28. Cholinergic stimulation of substantia nigra: abolition of carbachol-induced eating by unilateral 6-hydroxydopamine lesion of nigrostriatal dopamine neurones.
    Parker GC, Rugg EL, Winn P.
    Exp Brain Res; 1991 Sep 09; 87(3):597-603. PubMed ID: 1723691
    [Abstract] [Full Text] [Related]

  • 29. Two kinds of nigrostriatal asymmetry: relationship to dopaminergic drug sensitivity and 6-hydroxydopamine lesion effects in Long-Evans rats.
    Glick SD, Hinds PA, Baird JL.
    Brain Res; 1988 May 31; 450(1-2):334-41. PubMed ID: 3135915
    [Abstract] [Full Text] [Related]

  • 30. Association of dopamine D1 and D2 receptors with specific cellular elements in the basal ganglia of the cat: the uneven topography of dopamine receptors in the striatum is determined by intrinsic striatal cells, not nigrostriatal axons.
    Beckstead RM.
    Neuroscience; 1988 Dec 31; 27(3):851-63. PubMed ID: 3150855
    [Abstract] [Full Text] [Related]

  • 31. Supersensitivity of presynaptic receptors involved in the dopaminergic control of striatal high affinity glutamate uptake after 6-hydroxydopamine lesion of nigrostriatal dopaminergic neurons.
    Kerkerian L, Nieoullon A.
    Exp Brain Res; 1988 Dec 31; 69(2):424-30. PubMed ID: 2894320
    [Abstract] [Full Text] [Related]

  • 32. Tyrosine administration increases striatal dopamine release in rats with partial nigrostriatal lesions.
    Melamed E, Hefti F, Wurtman RJ.
    Proc Natl Acad Sci U S A; 1980 Jul 31; 77(7):4305-9. PubMed ID: 6254020
    [Abstract] [Full Text] [Related]

  • 33. Role of the substantia nigra in the expression of dopamine D1 receptor-mediated and D2 receptor-mediated behaviours.
    Fletcher GH, Starr MS.
    Neuroscience; 1987 Dec 31; 23(3):1001-10. PubMed ID: 2963970
    [Abstract] [Full Text] [Related]

  • 34. Altered melatonin MT1 receptor expression in the ventral midbrain following 6-hydroxydopamine lesions in the rat medial forebrain bundle.
    Kang NH, Carriere CH, Bahna SG, Niles LP.
    Brain Res; 2016 Dec 01; 1652():89-96. PubMed ID: 27693415
    [Abstract] [Full Text] [Related]

  • 35. Fetal ventral mesencephalic grafts functionally reduce the dopamine D2 receptor supersensitivity in partially dopamine reinnervated host striatum.
    Strömberg I, Kehr J, Andbjer B, Fuxe K.
    Exp Neurol; 2000 Jul 01; 164(1):154-65. PubMed ID: 10877926
    [Abstract] [Full Text] [Related]

  • 36. Dopamine receptors: effects of chronic L-dopa and bromocriptine treatment in an animal model of Parkinson's disease.
    Schneider MB, Murrin LC, Pfeiffer RF, Deupree JD.
    Clin Neuropharmacol; 1984 Jul 01; 7(3):247-57. PubMed ID: 6435870
    [Abstract] [Full Text] [Related]

  • 37. Dopaminergic functional supersensitivity: effects of chronic L-dopa and carbidopa treatment in an animal model of Parkinson's disease.
    Hossain MA, Weiner N.
    J Pharmacol Exp Ther; 1993 Dec 01; 267(3):1105-11. PubMed ID: 8263772
    [Abstract] [Full Text] [Related]

  • 38. Effect of chronic apomorphine on the development of denervation supersensitivity.
    Robin M, Forler C, Palfreyman MG.
    Pharmacol Biochem Behav; 1985 Apr 01; 22(4):547-51. PubMed ID: 3921992
    [Abstract] [Full Text] [Related]

  • 39. Chronic intranigral administration of brain-derived neurotrophic factor produces striatal dopaminergic hypofunction in unlesioned adult rats and fails to attenuate the decline of striatal dopaminergic function following medial forebrain bundle transection.
    Lapchak PA, Beck KD, Araujo DM, Irwin I, Langston JW, Hefti F.
    Neuroscience; 1993 Apr 01; 53(3):639-50. PubMed ID: 8098137
    [Abstract] [Full Text] [Related]

  • 40. Pharmacological characterization of dopaminergic influence on expression of neuropeptide Y immunoreactivity by rat striatal neurons.
    Kerkerian L, Salin P, Nieoullon A.
    Neuroscience; 1988 Sep 01; 26(3):809-17. PubMed ID: 3143926
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.